Europe Suffered Record Number of 'Extreme Heat Stress' Days in 2023

In a year of contrasting extremes, Europe witnessed scorching heatwaves but also catastrophic flooding, withering droughts, violent storms and its largest wildfire. Louisa GOULIAMAKI / AFP/File
In a year of contrasting extremes, Europe witnessed scorching heatwaves but also catastrophic flooding, withering droughts, violent storms and its largest wildfire. Louisa GOULIAMAKI / AFP/File
TT

Europe Suffered Record Number of 'Extreme Heat Stress' Days in 2023

In a year of contrasting extremes, Europe witnessed scorching heatwaves but also catastrophic flooding, withering droughts, violent storms and its largest wildfire. Louisa GOULIAMAKI / AFP/File
In a year of contrasting extremes, Europe witnessed scorching heatwaves but also catastrophic flooding, withering droughts, violent storms and its largest wildfire. Louisa GOULIAMAKI / AFP/File

Europe endured a record number of "extreme heat stress" days in 2023, two leading climate monitors said Monday, underscoring the threat of increasingly deadly summers across the continent.
In a year of contrasting extremes, Europe witnessed scorching heatwaves but also catastrophic flooding, withering droughts, violent storms and its largest wildfire, said AFP.
These disasters inflicted billions of dollars in damages and impacted more than two million people, the EU's Copernicus Climate Change Service and the UN's World Meteorological Organization (WMO) said in a new joint report.
The consequences for health were particularly acute, with heat singled out by these agencies as the biggest climate-related threat as global warming drives ever-hotter European summers.
"We're seeing an increasing trend in the number of days with heat stress across Europe and 2023 was no exception, with Europe seeing a record number of days with extreme heat stress," said Rebecca Emerton, a climate scientist at Copernicus.
For this study, Copernicus and WMO used the Universal Thermal Climate Index, which measures the effect of the environment on the human body.
It takes into account not just high temperatures but also humidity, wind speed, sunshine, and heat emitted by the surroundings.
The index has 10 different categories of heat and cold stress, with units of degrees Celsius representing a 'feels-like' temperature.
Extreme heat stress "is equivalent to a feels-like temperature of more than 46 degrees Celsius, at which point it's imperative to take actions to avoid health risks such as heat stroke", said Emerton.
- 'Extended summer' -
Prolonged exposure to heat stress is particularly dangerous for vulnerable people such as the elderly or those with pre-existing health conditions.
The effect of heat is stronger in cities, the report said.

Twenty three of the 30 worst heatwaves on record in Europe have occurred this century and heat-related deaths have soared around 30 percent in the past 20 years, the report said.
2023 was not the hottest summer in Europe -- in fact, it was the fifth -- but that doesn't mean it wasn't blazing.
Much of Europe sweltered from heatwaves during an "extended summer" between June and September, Emerton said.
September was the warmest on record for Europe as a whole, she added.
On July 23, an unprecedented 13 percent of Europe was experiencing high levels of heat stress, with southern Europe the worst affected.
The data on deaths in Europe from extreme heat in 2023 is not available yet.
But tens of thousands of people are estimated to have died due to heatwaves during equally sweltering European summers in 2003, 2010 and 2022, the report said.
"We see that there is excess mortality when we see such extreme heatwaves like was the case in 2023," said Alvaro Silva, a climatologist from WMO.
"This increase in mortality... is affecting (the) big majority of European regions. This is a big concern."
Serious consequences
Scientists agree that greenhouse gas emissions are warming the planet, causing more intense and frequent extreme weather events.
Europe is warming twice as fast as the global average and heatwaves will become longer and more powerful in future, the report said.
This -- coupled with aging populations and more people moving to cities -- will have "serious consequences for public health", it added.
"Current heatwave interventions will soon be insufficient to deal with the expected heat-related health burden."
2023 was the hottest year globally on record and oceans, which absorb 90 percent of excess heat produced by carbon dioxide emissions, also warmed to new highs.
Average sea surface temperatures in Europe were the warmest on record, the report said, with a severe marine heatwave in part of the Atlantic Ocean described as "beyond extreme".
Glaciers in all parts of Europe saw a loss of ice, while Greece suffered the largest wildfire in the history of the EU.
2023 was also one of Europe's wettest years, with major flooding affecting 1.6 million people, and storms another 550,000.
Emerton said that the economic cost of these extreme events was 13.4 billion euros ($14.3 billion) -- about 80 percent attributed to flooding.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”